October 30, 2019
Arrevus can advance ARV-1801 for the treatment of Pulmonary Exacerbations in Cystic Fibrosis Patients
RALEIGH, N.C.–(BUSINESS WIRE)–Arrevus Inc. (www.arrevus.com), a biotechnology company developing novel therapeutics for patients with unmet medical needs, today announced the…